Medtronic lifts sales and profit

AMERICAN medical device maker Medtronic reported higher quarterly earnings yesterday as sales in most of its businesses improved.

Earnings were $871m (£556m), or 82 cents per share, in the second quarter ended 28 October, compared with $566m, or 52 cents per share, a year earlier.

Revenue rose to $4.13bn from $3.90bn a year ago, even as sales of implantable heart defibrillators and spine biologics remained weak, as expected. For the second half, the company maintained its revenue forecast.